China Peptide Synthesis Market Size & Outlook, 2025-2033

The peptide synthesis market in China is expected to reach a projected revenue of US$ 158.9 million by 2033. A compound annual growth rate of 9.7% is expected of China peptide synthesis market from 2025 to 2033.
Revenue, 2024 (US$M)
$71.1
Forecast, 2033 (US$M)
$158.9
CAGR, 2025 - 2033
9.7%
Report Coverage
China

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

China peptide synthesis market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

China peptide synthesis market highlights

  • The China peptide synthesis market generated a revenue of USD 71.1 million in 2024 and is expected to reach USD 158.9 million by 2033.
  • The China market is expected to grow at a CAGR of 9.7% from 2025 to 2033.
  • In terms of segment, reagents & consumables was the largest revenue generating product in 2024.
  • Equipment is the most lucrative product segment registering the fastest growth during the forecast period.


Peptide synthesis market data book summary

Market revenue in 2024USD 71.1 million
Market revenue in 2033USD 158.9 million
Growth rate9.7% (CAGR from 2025 to 2033)
Largest segmentReagents & consumables
Fastest growing segmentEquipment
Historical data2021 - 2023
Base year2024
Forecast period2025 - 2033
Quantitative unitsRevenue in USD million
Market segmentationReagents & Consumables, Equipment, Service
Key market players worldwideThermo Fisher Scientific Inc, Merck KGaA, GenScript, Bachem Holding AG, Biotage, Creative Diagnostics, PolyPeptide Group AG, Syngene, Lonza


Other key industry trends

  • In terms of revenue, China accounted for 7.4% of the global peptide synthesis market in 2024.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
  • In Asia Pacific, China peptide synthesis market is projected to lead the regional market in terms of revenue in 2033.
  • India is the fastest growing regional market in Asia Pacific and is projected to reach USD 71.3 million by 2033.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Peptide Synthesis Market Companies

Name Profile # Employees HQ Website
Lonza View profile - - -
GenScript View profile - - -
Biotage View profile 501-1000 Uppsala, Uppsala Lan, Sweden, Europe http://www.biotage.com
Syngene View profile 1001-5000 Bangalore, Karnataka, India, Asia http://www.syngeneintl.com
Creative Diagnostics View profile 51-100 New York, New York, United States, North America http://www.creative-diagnostics.com
Bachem Holding AG View profile 2006 Hauptstrasse 144, Bubendorf, Switzerland, 4416 https://www.bachem.com
PolyPeptide Group AG View profile 1273 Neuhofstrasse 24, Baar, Zug, Switzerland, 6340 https://www.polypeptide.com
Thermo Fisher Scientific Inc View profile 122000 168 Third Avenue, Waltham, MA, United States, 02451 https://www.thermofisher.com
Merck KGaA View profile 62345 Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 https://www.emdgroup.com

China peptide synthesis market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to peptide synthesis market will help companies and investors design strategic landscapes.


Reagents & consumables was the largest segment with a revenue share of 53.16% in 2024. Horizon Databook has segmented the China peptide synthesis market based on reagents & consumables, equipment, service covering the revenue growth of each sub-segment from 2021 to 2033.


The Chinese peptide synthesis market is expected to grow in the forecast period. Chinese companies have significantly increased their investments in synthesizing peptides and improving process technologies. For instance, in January 2025, BioDuro inaugurated a fully automated solid-phase peptide synthesis scale-up laboratory at its Shanghai Zhangjiang High-tech Park campus in China.

This state-of-the-art facility has automated solid-phase peptide synthesizers, cleavage systems, and freeze-drying equipment, supporting peptide synthesis scale-up to 800 mmol. This expansion enhances BioDuro’s capabilities to meet the growing global demand for efficient and scalable peptide manufacturing and make peptide drugs available worldwide, driving market growth.

Reasons to subscribe to China peptide synthesis market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of China peptide synthesis market databook

  • Our clientele includes a mix of peptide synthesis market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the China peptide synthesis market , including forecasts for subscribers. This country databook contains high-level insights into China peptide synthesis market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

China peptide synthesis market size, by product, 2021-2033 (US$M)

China Peptide Synthesis Market Outlook Share, 2024 & 2033 (US$M)

China peptide synthesis market size, by product, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online